PL354872A1 - Doustna postać dawki zawierająca sól morfiny lub pochodnej morfiny - Google Patents

Doustna postać dawki zawierająca sól morfiny lub pochodnej morfiny

Info

Publication number
PL354872A1
PL354872A1 PL00354872A PL35487200A PL354872A1 PL 354872 A1 PL354872 A1 PL 354872A1 PL 00354872 A PL00354872 A PL 00354872A PL 35487200 A PL35487200 A PL 35487200A PL 354872 A1 PL354872 A1 PL 354872A1
Authority
PL
Poland
Prior art keywords
morphine
salt
dosage form
oral dosage
derivative
Prior art date
Application number
PL00354872A
Other languages
English (en)
Inventor
Sonja Joran Ugarkovic
Original Assignee
Alkaloid Ad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9925069A external-priority patent/GB2355406A/en
Priority claimed from GB0014497A external-priority patent/GB0014497D0/en
Application filed by Alkaloid Ad filed Critical Alkaloid Ad
Publication of PL354872A1 publication Critical patent/PL354872A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL00354872A 1999-10-23 2000-09-07 Doustna postać dawki zawierająca sól morfiny lub pochodnej morfiny PL354872A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9925069A GB2355406A (en) 1999-10-23 1999-10-23 A sub-lingual dosage form comprising a morphine salt
GB0014497A GB0014497D0 (en) 2000-06-15 2000-06-15 Oral dosage form

Publications (1)

Publication Number Publication Date
PL354872A1 true PL354872A1 (pl) 2004-03-08

Family

ID=26244484

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354872A PL354872A1 (pl) 1999-10-23 2000-09-07 Doustna postać dawki zawierająca sól morfiny lub pochodnej morfiny

Country Status (7)

Country Link
EP (1) EP1221944A1 (pl)
AR (1) AR025791A1 (pl)
AU (1) AU7023200A (pl)
CA (1) CA2388123A1 (pl)
PL (1) PL354872A1 (pl)
RU (1) RU2002110329A (pl)
WO (1) WO2001030321A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
US9127008B2 (en) 2013-03-15 2015-09-08 Johnson Matthey Public Limited Company Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080047B1 (en) * 1981-11-23 1985-05-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Analgesic compositions containing an opiate alkaloid compound and a carbazole compound
US5580876A (en) * 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
JP3030422B2 (ja) * 1992-09-30 2000-04-10 アール．ピー．シェーラー コーポレーション 段付端部を有するブリスターパック及びその製法
US5811126A (en) * 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
DE19758564A1 (de) * 1997-11-11 1999-08-26 Gruenenthal Gmbh Formulierung einer Kombination aus Morphin und einem alpha¶2¶-adrenergem Agonisten und deren Verwendung

Also Published As

Publication number Publication date
AR025791A1 (es) 2002-12-11
EP1221944A1 (en) 2002-07-17
AU7023200A (en) 2001-05-08
CA2388123A1 (en) 2001-05-03
WO2001030321A1 (en) 2001-05-03
RU2002110329A (ru) 2003-11-20

Similar Documents

Publication Publication Date Title
HUP0203204A3 (en) Oral dosage forms
IL149224A0 (en) Hydrogen-driven drug dosage form
IL148407A0 (en) Oral pharmaceutical forms of administration with a delayed action
IL146928A0 (en) Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
IL191582A0 (en) Polymorph of a pharmaceutical
IL148406A0 (en) Pharmaceutical tramadol salts
SI1390023T1 (sl) Farmacevtske soli spojin 1-fenil-3-dimetilamino-propana
SG109439A1 (en) Sulfonium salt compounds
IL145632A0 (en) Pharmaceutical compounds
ZA200203100B (en) A salt of morphine.
GB9916434D0 (en) Pharmaceutical compounds
EP1233755A4 (en) GRANULES OF MEDICINAL SALTS WITH HYDROLIZED CELLULOSE
HUP0201667A3 (en) Oral form of administration
GB9914255D0 (en) Pharmaceutical compounds
IL147496A0 (en) Preparation of a therapeutic composition
GB9903784D0 (en) Pharmaceutical compounds
PL354872A1 (pl) Doustna postać dawki zawierająca sól morfiny lub pochodnej morfiny
IL146408A0 (en) Diphosphate salt of a 4-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition
EP1114642A4 (en) MEDICAMENTS FOR THE TREATMENT OF PERIODONTAL DISEASES
GB2373499B (en) Pharmaceutical compounds
AU1878001A (en) Shower head containing a dose of water-soluble substance
HUP0204547A3 (en) Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms
HU9904011D0 (en) Novel salts of dipeptid derivatives
GB9925069D0 (en) Oral dosage form
SI1252133T1 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)